论文部分内容阅读
一、前言乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染在肝细胞癌(HCC)的发生发展中起重要作用。我国近年发布的《慢性乙型肝炎防治指南(2010版)》和《原发性肝癌诊疗规范(2011版)》都强调了肝癌患者抗病毒治疗的重要性,但未作深入具体阐述。《丙型肝炎防治指南(2004版)》也注意到抗病毒治疗延缓HCC的发生。有鉴于此,中华医学会肝病学分会肝癌学组召开了三次专题讨论会,系统收集分析了现有HCC综合治疗中抗病毒治疗的临床研究文献,回顾了HCC治疗中抗病毒
I. Introduction Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection play an important role in the development of hepatocellular carcinoma (HCC). In recent years, China has pointed out the importance of antiretroviral therapy in patients with liver cancer. However, it has not been elaborated in more depth in the Guide to Prevention and Treatment of Chronic Hepatitis B (2010 Edition) and the Guidelines for Diagnosis and Treatment of Primary Hepatocellular Carcinoma (2011 Edition). Guidelines for the Prevention and Treatment of Hepatitis C (2004 Edition) also note that antiviral therapy delays the onset of HCC. In view of this, the Chinese Medical Association of Liver Diseases Branch of liver cancer held three symposia, systematic collection and analysis of existing HCC comprehensive treatment of antiviral treatment of clinical research literature review HCC treatment of antiviral